MSD 結果共3筆

Legislators and veterinarian groups in Taiwan are calling for an expedited process to grant treatment approval for Feline Infectious Peritonitis (FIP), a highly fatal disease for cats. FIP is particularly prevalent in cats with weakened immune systems, such as older or younger cats, and has an almost 100% mortality rate. Diagnosing and preventing the disease is challenging, and currently, there are no legal medications for FIP in Taiwan. Legislator Kao Chia-yu, in collaboration with veterinarian groups, is working to provide hope for cats suffering from FIP. Research has shown that GS-441524 tablets have curative effects, but the application process for animal medication has been halted due to the COVID-19 outbreak. During a press conference, the president of the Taiwan Academy of Veterinary Internal Medicine, Chung Sheng-hua, highlighted that Remdesivir, a COVID-19 medication, and Molnupiravir from MSD have also demonstrated effectiveness against FIP. Chung urged relevant authorities to expedite the legalization of these drugs to obtain the necessary animal medication permits.

巴西克魯茲基金會（Fiocruz）今天宣布與美國默沙東製藥公司（MSD）簽署合作協議，將生產針對COVID-19的口服抗病毒藥物「莫納皮拉韋」（Molnupiravir）。

日本有不少女性在接種子宮頸癌疫苗後，出現嚴重副作用，有人腳部失去知覺，從此只能用輪椅代步，有人從此畏光，墨鏡不能離身，更有人記憶力受損，想不起昨天發生的事情。因此，有63名受害女性27日集體控告日本政府及2家藥廠，要求賠償每人460萬元台幣。